High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility study.

F Ferrara; M Annunziata; E M Schiavone; C Copia; M De Simone; F Pollio; S Palmieri; A Viola; C Russo; G Mele

doi:10.1038/sj.thj.6200122

High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility study.

Identifier:nobleid.org/w1/20260515/742CEEB5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/742CEEB5.svg?ark=w1%2F20260515%2F742CEEB5)](https://nobleid.org/work/w1/20260515/742CEEB5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

High-dose idarubicin and busulphan as conditioning for autologous stem cell transplantation in acute myeloid leukemia: a feasibility study.

Identifier:nobleid.org/w1/20260515/742CEEB5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/742CEEB5.svg?ark=w1%2F20260515%2F742CEEB5)](https://nobleid.org/work/w1/20260515/742CEEB5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work